{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T04:38:30Z","timestamp":1794285510347,"version":"4.9.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.metabol.2023.155659","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T12:13:58Z","timestamp":1689077638000},"page":"155659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: Is there a role for statin therapy?"],"prefix":"10.1016","volume":"146","author":[{"given":"Amirhossein","family":"Sahebkar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Foroutan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Katsiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tannaz","family":"Jamialahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos S.","family":"Mantzoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.metabol.2023.155659_bb0005","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.metabol.2023.155659_bb0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.metabol.2023.155659_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","article-title":"The hallmarks of ferroptosis","volume":"3","author":"Dixon","year":"2019","journal-title":"Annu Rev Cancer Biol"},{"key":"10.1016\/j.metabol.2023.155659_bb0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.freeradbiomed.2015.07.019","article-title":"Iron and oxidative stress in cardiomyopathy in thalassemia","volume":"88","author":"Berdoukas","year":"2015","journal-title":"Free Radic Biol Med"},{"issue":"11","key":"10.1016\/j.metabol.2023.155659_bb0025","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1111\/cas.13380","article-title":"Lipoxygenase-mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3","volume":"108","author":"Shintoku","year":"2017","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.metabol.2023.155659_bb0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"issue":"17","key":"10.1016\/j.metabol.2023.155659_bb0035","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.3390\/cells11172726","article-title":"Molecular mechanisms of ferroptosis and relevance to cardiovascular disease","volume":"11","author":"Xie","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.metabol.2023.155659_bb0040","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/biomedicines10040891","article-title":"The selenoprotein glutathione peroxidase 4: from molecular mechanisms to novel therapeutic opportunities","volume":"10","author":"Weaver","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.metabol.2023.155659_bb0045","series-title":"Drug-resistance in cancer cells: a new wine in an old bottle","article-title":"System X c-\/GSH\/GPX4 axis: an important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy","volume":"114","author":"Li","year":"2023"},{"key":"10.1016\/j.metabol.2023.155659_bb0050","series-title":"Seminars in cancer biology","article-title":"Effects of statins on brain tumors: a review","year":"2021"},{"issue":"1","key":"10.1016\/j.metabol.2023.155659_bb0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.metabol.2023.155659_bb0060","doi-asserted-by":"crossref","first-page":"20607","DOI":"10.3390\/ijms151120607","article-title":"Molecular mechanisms underlying the effects of statins in the central nervous system","volume":"15","author":"McFarland","year":"2014","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.metabol.2023.155659_bb0065","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.tcb.2015.10.014","article-title":"Ferroptosis: death by lipid peroxidation","volume":"26","author":"Yang","year":"2016","journal-title":"Trends Cell Biol"},{"issue":"9\u201310","key":"10.1016\/j.metabol.2023.155659_bb0070","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1101\/gad.314674.118","article-title":"Regulation of lipid peroxidation and ferroptosis in diverse species","volume":"32","author":"Conrad","year":"2018","journal-title":"Genes Dev"},{"issue":"3","key":"10.1016\/j.metabol.2023.155659_bb0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3390\/antiox11030501","article-title":"Superoxide radicals in the execution of cell death","volume":"11","author":"Fujii","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.metabol.2023.155659_bb0080","first-page":"2022","article-title":"Atorvastatin inhibits ferroptosis of H9C2 cells by regulatingSMAD7\/Hepcidin expression to improve ischemia-reperfusion injury","author":"Peng","year":"2022","journal-title":"Cardiol Res Pract"},{"issue":"4","key":"10.1016\/j.metabol.2023.155659_bb0085","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/CIRCRESAHA.120.316509","article-title":"Loss of cardiac ferritin H facilitates cardiomyopathy via Slc7a11-mediated ferroptosis","volume":"127","author":"Fang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2023.155659_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105466","article-title":"Ferroptosis and its emerging roles in cardiovascular diseases","volume":"166","author":"Li","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.metabol.2023.155659_bb0095","article-title":"Targeting ferroptosis to treat cardiovascular diseases: a new continent to be explored","volume":"9","author":"Huang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.metabol.2023.155659_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154840","article-title":"FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis","volume":"122","author":"Pei","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155659_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154397","article-title":"Beclin1 haploinsufficiency rescues low ambient temperature-induced cardiac remodeling and contractile dysfunction through inhibition of ferroptosis and mitochondrial injury","volume":"113","author":"Yin","year":"2020","journal-title":"Metabolism"},{"issue":"21","key":"10.1016\/j.metabol.2023.155659_bb0110","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.3390\/ijms21217889","article-title":"The molecular mechanisms of iron metabolism and its role in cardiac dysfunction and cardioprotection","volume":"21","author":"Ravingerov\u00e1","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.metabol.2023.155659_bb0115","first-page":"1","article-title":"Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.metabol.2023.155659_bb0120","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/biom12030390","article-title":"Ferroptosis in cardiovascular diseases: current status, challenges, and future perspectives","volume":"12","author":"Guo","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.metabol.2023.155659_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbrc.2021.08.017","article-title":"Atorvastatin treatment ameliorates cardiac function and remodeling induced by isoproterenol attack through mitigation of ferroptosis","volume":"574","author":"Ning","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.metabol.2023.155659_bb0130","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","article-title":"Ferroptosis in cancer therapy: a novel approach to reversing drug resistance","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol Cancer"},{"key":"10.1016\/j.metabol.2023.155659_bb0135","first-page":"5015","article-title":"Microenvironment immune response induced by tumor ferroptosis\u2014the application of nanomedicine","author":"Yun","year":"2022","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.metabol.2023.155659_bb0140","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/14728222.2021.2011206","article-title":"The mechanisms and therapeutic targets of ferroptosis in cancer","volume":"25","author":"Ye","year":"2021","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"10.1016\/j.metabol.2023.155659_bb0145","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3390\/cancers12010164","article-title":"Ferroptosis in cancer cell biology","volume":"12","author":"Bebber","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.metabol.2023.155659_bb0150","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.2147\/OTT.S232852","article-title":"Ferroptosis in carcinoma: regulatory mechanisms and new method for cancer therapy","volume":"12","author":"Shi","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.metabol.2023.155659_bb0155","first-page":"12","article-title":"Ferroptosis: a new strategy for cancer therapy","author":"Chen","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.metabol.2023.155659_bb0160","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/BCTT.S336712","article-title":"Potentiating the cytotoxic activity of a novel simvastatin-loaded cubosome against breast cancer cells: insights on dual cell death via ferroptosis and apoptosis","volume":"13","author":"Elakkad","year":"2021","journal-title":"Breast Cancer Target Ther"},{"issue":"10","key":"10.1016\/j.metabol.2023.155659_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077060","article-title":"Long chain fatty Acyl-CoA synthetase 4 is a biomarker for and mediator of hormone resistance in human breast cancer","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.metabol.2023.155659_bb0170","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat Chem Biol"},{"issue":"1","key":"10.1016\/j.metabol.2023.155659_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-021-01058-1","article-title":"Simvastatin induced ferroptosis for triple-negative breast cancer therapy","volume":"19","author":"Yao","year":"2021","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.metabol.2023.155659_bb0180","first-page":"2022","article-title":"Simvastatin inhibits endometrial cancer malignant behaviors by suppressing RAS\/mitogen-activated protein kinase (MAPK) pathway-mediated reactive oxygen species (ROS) and ferroptosis","author":"Zhou","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"issue":"18","key":"10.1016\/j.metabol.2023.155659_bb0185","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161940","article-title":"Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non\u2013small cell lung cancer","volume":"7","author":"Mao","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2023.155659_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.761107","article-title":"Targeting the tumor microenvironment: a literature review of the novel anti-tumor mechanism of statins","volume":"11","author":"Zhu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.metabol.2023.155659_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02041-2","article-title":"Statins: a repurposed drug to fight cancer","volume":"40","author":"Jiang","year":"2021","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.metabol.2023.155659_bb0200","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.4103\/1673-5374.358614","article-title":"Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration","volume":"18","author":"Villal\u00f3n-Garc\u00eda","year":"2023","journal-title":"Neural Regen Res"},{"issue":"22","key":"10.1016\/j.metabol.2023.155659_bb0205","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.3390\/ijms21228765","article-title":"Ferroptosis mechanisms involved in neurodegenerative diseases","volume":"21","author":"Reichert","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.metabol.2023.155659_bb0210","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11033-022-08048-y","article-title":"The role of ferroptosis in neurodegenerative diseases","volume":"50","author":"Xu","year":"2023","journal-title":"Mol Biol Rep"},{"issue":"12","key":"10.1016\/j.metabol.2023.155659_bb0215","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014852","article-title":"Effect of statins on Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"98","author":"Yan","year":"2019","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.metabol.2023.155659_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152564","article-title":"Statin use and the risk of Parkinson\u2019s disease: an updated meta-analysis","volume":"11","author":"Bai","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.metabol.2023.155659_bb0225","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/eurjpc\/zwab208","article-title":"Statin use and risk of dementia or Alzheimer\u2019s disease: a systematic review and meta-analysis of observational studies","volume":"29","author":"Olmastroni","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"3","key":"10.1016\/j.metabol.2023.155659_bb0230","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/jgs.16342","article-title":"Benefits and harms of statins in people with dementia: a systematic review and meta-analysis","volume":"68","author":"Davis","year":"2020","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.metabol.2023.155659_bb0235","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.metabol.2023.155659_bb0240","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41392-022-01119-3","article-title":"Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver\/steatohepatitis (NAFL\/NASH)","volume":"7","author":"Xu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"3","key":"10.1016\/j.metabol.2023.155659_bb0245","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1570161115666170621075619","article-title":"Is nonalcoholic fatty liver disease indeed the hepatic manifestation of metabolic syndrome?","volume":"16","author":"Katsiki","year":"2018","journal-title":"Curr Vasc Pharmacol"},{"issue":"8","key":"10.1016\/j.metabol.2023.155659_bb0250","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.metabol.2016.05.003","article-title":"Non-alcoholic fatty liver disease and dyslipidemia: an update","volume":"65","author":"Katsiki","year":"2016","journal-title":"Metabolism"},{"issue":"7","key":"10.1016\/j.metabol.2023.155659_bb0255","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/HYPERTENSIONAHA.122.17982","article-title":"Nonalcoholic fatty liver disease and cardiovascular disease: a review of shared cardiometabolic risk factors","volume":"79","author":"Muzurovi\u0107","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.metabol.2023.155659_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154770","article-title":"Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk","volume":"119","author":"Muzurovi\u0107","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155659_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155222","article-title":"Association of fatty liver index with all-cause and disease-specific mortality: a nationwide cohort study","volume":"133","author":"Chung","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155659_bb0270","article-title":"A healthy lifestyle, Life\u2019s Essential 8 scores and new-onset severe NAFLD: a prospective analysis in UK Biobank","volume":"155643","author":"He","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155659_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154873","article-title":"Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk","volume":"124","author":"van den Hoek","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155659_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106679","article-title":"Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): a position paper from the International Lipid Expert Panel (ILEP)","volume":"189","author":"Rizzo","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.metabol.2023.155659_bb0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.artere.2022.07.002","article-title":"Dietary patterns in non-alcoholic fatty liver disease (NAFLD): stay on the straight and narrow path!","volume":"34","author":"Katsiki","year":"2022","journal-title":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis (English Edition)"},{"key":"10.1016\/j.metabol.2023.155659_bb0290","article-title":"The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials","volume":"155136","author":"Angelidi","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155659_bb0295","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.atherosclerosis.2019.02.028","article-title":"Statins and nonalcoholic fatty liver disease in the era of precision medicine: more friends than foes","volume":"284","author":"Nascimbeni","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.metabol.2023.155659_bb0300","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.metabol.2017.02.014","article-title":"The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement","volume":"71","author":"Athyros","year":"2017","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.metabol.2023.155659_bb0305","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.clnu.2022.08.001","article-title":"Statins\u2019 efficacy in non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"41","author":"Boutari","year":"2022","journal-title":"Clin Nutr"},{"key":"10.1016\/j.metabol.2023.155659_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154796","article-title":"Long-term statin treatment for hepatic fibrosis in patients with nonalcoholic fatty liver disease: is it time to give the emperor a statin robe?","volume":"121","author":"Tessier","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2023.155659_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2021.154752","article-title":"Statin use is associated with lower prevalence of advanced liver fibrosis in patients with type 2 diabetes","volume":"121","author":"Ciardullo","year":"2021","journal-title":"Metabolism"},{"issue":"20","key":"10.1016\/j.metabol.2023.155659_bb0320","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.3390\/nu14204365","article-title":"Statin-induced geranylgeranyl pyrophosphate depletion promotes ferroptosis-related senescence in adipose tissue","volume":"14","author":"Shu","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2023.155659_bb0325","first-page":"10","article-title":"Atorvastatin induces mitochondria-dependent ferroptosis via the modulation of Nrf2-xCT\/GPx4 axis","author":"Zhang","year":"2022","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"10.1016\/j.metabol.2023.155659_bb0330","doi-asserted-by":"crossref","first-page":"C1208","DOI":"10.1152\/ajpcell.00226.2006","article-title":"Statin-induced apoptosis and skeletal myopathy","volume":"291","author":"Dirks","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.metabol.2023.155659_bb0335","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/ijms23010128","article-title":"The roles of coenzyme Q in disease: direct and indirect involvement in cellular functions","volume":"23","author":"Pallotti","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.metabol.2023.155659_bb0340","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.phrs.2015.07.008","article-title":"Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Statin therapy and plasma coenzyme Q10 concentrations\u2014a systematic review and meta-analysis of placebo-controlled trials","volume":"99","author":"Banach","year":"2015","journal-title":"Pharmacol Res"},{"issue":"19","key":"10.1016\/j.metabol.2023.155659_bb0345","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009835","article-title":"Effects of coenzyme Q10 on statin-induced myopathy: an updated meta-analysis of randomized controlled trials","volume":"7","author":"Qu","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.metabol.2023.155659_bb0350","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.mayocp.2014.08.021","article-title":"Lipid and Blood Pressure Meta-analysis Collaboration Group. Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials","volume":"90","author":"Banach","year":"2015","journal-title":"Mayo Clin Proc"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049523002639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049523002639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T19:37:35Z","timestamp":1736365055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049523002639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":70,"alternative-id":["S0026049523002639"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155659","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ferroptosis, a new pathogenetic mechanism in cardiometabolic diseases and cancer: Is there a role for statin therapy?","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2023.155659","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"155659"}}